Drawing for PREDICTSURE

USPTO serial 79259194

PREDICTSURE

Reviewed by CopyMark Law Group

Reg. 6039264Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2020
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PREDICTSURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic and prognostic reagents and preparations for medical purposes; diagnostic and prognostic reagents and preparations for laboratory testing for medical purposes, including laboratory testing of samples from patientsACTIVE—
010Diagnostic and prognostic apparatuses, devices and instruments for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic apparatuses, devices and instruments for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitisACTIVE—
042Computer-aided diagnostic and prognostic testing services, including analyzing samples from patients to provide diagnosis and prognosis and guiding treatment options, namely, medical laboratory services; software as a service (Saas) services featuring software for diagnosis and prognosis of immune-related diseases; software as a service (SaaS) services featuring software for providing diagnostic or prognostic results and guiding treatment options based on data from patient samples; design and development of diagnostic and prognostic apparatus, devices, kits and instruments; medical and scientific research, design and development of diagnostic and prognostic tests, including diagnostic and prognostic tests relating to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitisACTIVE—
044Medical services, including diagnostic and prognostic services, guiding treatment options; RNA and DNA analysis, namely, genetic testing for medical purposes; medical analysis services for the diagnosis, prognosis and treatment of persons provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 12, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 6, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 31, 2020FIMPFINAL DISPOSITION PROCESSED—
Jul 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 29, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 12, 2019RFNPREFUSAL PROCESSED BY IB—
Jun 22, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 22, 2019RFRRREFUSAL PROCESSED BY MPU—
Jun 4, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
May 28, 2019DOCKASSIGNED TO EXAMINER—
May 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 23, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance